CD82 and prostate cancer: RT-PCR analyses, which confirmed that PC3 prostate cancer cells express high levels of VEGF, showed that KAI1 expression repressed the expression of three VEGF isoforms (VEGF189, VEGF165, and VEGF121; Figure 5D).